Stephen Connelly Ph.D.
Net Worth
Last updated:
What is Stephen Connelly Ph.D. net worth?
The estimated net worth of Dr. Stephen Connelly Ph.D. is at least $6,302,079 as of 6 Oct 2021. He owns shares worth $1,261,110 as insider, has earned $2,457,919 from insider trading and has received compensation worth at least $2,583,050 in Equillium, Inc..
What is the salary of Stephen Connelly Ph.D.?
Dr. Stephen Connelly Ph.D. salary is $516,610 per year as Chief Scientific Officer & Director in Equillium, Inc..
How old is Stephen Connelly Ph.D.?
Dr. Stephen Connelly Ph.D. is 43 years old, born in 1982.
What stocks does Stephen Connelly Ph.D. currently own?
As insider, Dr. Stephen Connelly Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Equillium, Inc. (EQ) | Chief Scientific Officer & Director | 993,000 | $1.27 | $1,261,110 |
What does Equillium, Inc. do?
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Stephen Connelly Ph.D. insider trading
Equillium, Inc.
Dr. Stephen Connelly Ph.D. has made 7 insider trades between 2020-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 250,000 units of EQ stock on 13 Jul 2020. As of 6 Oct 2021 he still owns at least 993,000 units of EQ stock.
Equillium key executives
Equillium, Inc. executives and other stock owners filed with the SEC:
- Dr. Krishna R. Polu (52) Consultant
- Dr. Stephen Connelly Ph.D. (43) Chief Scientific Officer & Director
- Mr. Bruce D. Steel C.F.A. (59) Co-Founder, Pres, Chief Executive Officer & Director
- Mr. Daniel Mark Bradbury (64) Executive Chairman